Analyst Rating Update on Hill-Rom Holdings Inc (HRC)

Hill-Rom Holdings Inc (HRC) : Zacks Investment Research ranks Hill-Rom Holdings Inc (HRC) as 3, which is a Hold recommendation. 3 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 other analysts are mildly bullish on the stock and favor a Buy. A total of 2 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 6 research analysts is 1.75, which indicates as a Buy.

Hill-Rom Holdings Inc (HRC) : The most positive equity analysts on Hill-Rom Holdings Inc (HRC) expects the shares to touch $69, whereas, the least positive believes that the stock will trade at $58 in the short term. The company is covered by 4 Wall Street Brokerage Firms. The average price target for shares are $62 with an expected fluctuation of $4.97 from the mean.

For the current week, the company shares have a recommendation consensus of Buy.


Hill-Rom Holdings Inc (NYSE:HRC): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $53.91 and $53.51 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $54.37. The buying momentum continued till the end and the stock did not give up its gains. It closed at $54.28, notching a gain of 0.82% for the day. The total traded volume was 843,443 . The stock had closed at $53.84 on the previous day.

Hill-Rom Holdings, Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. The Company operates in three segments: North America, Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services, as well as its clinical workflow solutions, in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.